Literature DB >> 2304283

The influence of hyperthermia in vitro on the functions of peritoneal macrophages in mice.

H Yoshioka1, S Koga, M Maeta, N Shimizu, R Hamazoe, A Murakami.   

Abstract

Total-body hyperthermia (TBHT) as a treatment for cancer may lead to a reduction in the host's immunocompetence as a result of the direct effects of heat on the immune system. Thus, we studied the influences of hyperthermia in vitro on the function of peritoneal macrophages from mice. Peritoneal macrophages from C3H/HeN mice were heated in vitro for 3 hr at 37, 39, 40, 41 or 42 degrees C. After exposure to heat, the phagocytic ability of the macrophages, as well as results of the nitroblue tetrazolium (NBT) reduction test and the cytotoxicity test were examined. The changes in all these parameters showed almost the same pattern: a tendency for macrophage functions to be potentiated up to 40 degrees C, and a tendency towards inhibited functioning at temperatures above 41 degrees C. Although augmented functions of macrophages were observed after exposure to mild hyperthermia (less than 40 degrees C), the possibility of TBHT (42 degrees C)-induced inhibition of macrophage function must be further investigated in clinical trials of TBHT therapy for cancer.

Entities:  

Mesh:

Year:  1990        PMID: 2304283     DOI: 10.1007/bf02470725

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  12 in total

1.  The demonstration of acid alpha-naphthyl acetate esterase activity in human lymphocytes: usefulness as a T-cell marker.

Authors:  D M Knowles; T Hoffman; M Ferrarini; H G Kunkel
Journal:  Cell Immunol       Date:  1978-01       Impact factor: 4.868

2.  Infection and nitroblue-tetrazolium reduction by neutrophils. A diagnostic acid.

Authors:  B H Park; S M Fikrig; E M Smithwick
Journal:  Lancet       Date:  1968-09-07       Impact factor: 79.321

3.  Sensitivity of human natural killer cells to hyperthermia.

Authors:  J Azocar; E J Yunis; M Essex
Journal:  Lancet       Date:  1982-01-02       Impact factor: 79.321

4.  The effects of total-body hyperthermia combined with anticancer drugs on immunity in advanced cancer patients.

Authors:  S Koga; A Izumi; M Maeta; N Shimizu; Y Osaki; H Kanayama
Journal:  Cancer       Date:  1983-10-01       Impact factor: 6.860

5.  Effects of hyperthermia on primary and metastatic tumor growth and host immune response in rats.

Authors:  M Schechter; S M Stowe; H Moroson
Journal:  Cancer Res       Date:  1978-03       Impact factor: 12.701

6.  Enhancement of spontaneous and lymphokine activated human macrophage cytotoxicity by hyperthermia.

Authors:  R Andreesen; J Osterholz; A Schulz; G W Löhr
Journal:  Blut       Date:  1983-10

7.  Hyperthermia: the immune response and tumor metastasis.

Authors:  J A Dickson; S A Shah
Journal:  Natl Cancer Inst Monogr       Date:  1982-06

8.  Effects of in vitro hyperthermia on human natural killer cells.

Authors:  T Kalland; I Dahlquist
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

9.  Effects of in vitro hyperthermia on murine and human lymphocytes.

Authors:  A Izumi; S Koga; M Maeta
Journal:  Cancer       Date:  1983-06-01       Impact factor: 6.860

10.  Participation of the immune system in regression of a rat Mc7 sarcoma by hyperthermia.

Authors:  S A Shah
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

View more
  8 in total

1.  Incubation of whole blood at 39°C augments gamma interferon (IFN-γ)-induced protein 10 and IFN-γ responses to Mycobacterium tuberculosis antigens.

Authors:  Martine G Aabye; Pernille Ravn; Isik S Johansen; Jesper Eugen-Olsen; Morten Ruhwald
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

Review 2.  Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function.

Authors:  Julie R Ostberg; Elizabeth A Repasky
Journal:  Cancer Immunol Immunother       Date:  2005-04-28       Impact factor: 6.968

Review 3.  Fever and the heat shock response: distinct, partially overlapping processes.

Authors:  J D Hasday; I S Singh
Journal:  Cell Stress Chaperones       Date:  2000-11       Impact factor: 3.667

Review 4.  Diverse immune mechanisms may contribute to the survival benefit seen in cancer patients receiving hyperthermia.

Authors:  Adrienne J Peer; Melissa J Grimm; Evan R Zynda; Elizabeth A Repasky
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

Review 5.  [Therapy of hyperthermia in sepsis and septic shock. Necessary or injurious?].

Authors:  H Theilen; M Ragaller
Journal:  Anaesthesist       Date:  2007-09       Impact factor: 1.041

Review 6.  Recent Progress in the Synergistic Combination of Nanoparticle-Mediated Hyperthermia and Immunotherapy for Treatment of Cancer.

Authors:  Zachary R Stephen; Miqin Zhang
Journal:  Adv Healthc Mater       Date:  2020-11-25       Impact factor: 9.933

Review 7.  Local tumour hyperthermia as immunotherapy for metastatic cancer.

Authors:  Seiko Toraya-Brown; Steven Fiering
Journal:  Int J Hyperthermia       Date:  2014-12       Impact factor: 3.914

Review 8.  Integrating Hyperthermia into Modern Radiation Oncology: What Evidence Is Necessary?

Authors:  Jan C Peeken; Peter Vaupel; Stephanie E Combs
Journal:  Front Oncol       Date:  2017-06-30       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.